Show simple item record

dc.contributor.authorLloyd-Evans, Phoebe
dc.contributor.authorBaldwin, Molly
dc.contributor.authorDaynes, Enya
dc.contributor.authorHong, Annabel
dc.contributor.authorMills, George
dc.contributor.authorGoddard, Amye
dc.contributor.authorChaplin, Emma
dc.contributor.authorGardiner, Nikki
dc.contributor.authorSingh, Sally
dc.date.accessioned2023-04-20T15:20:17Z
dc.date.available2023-04-20T15:20:17Z
dc.date.issued2022-09-28
dc.identifier.citationLloyd-Evans, P. H. I., Baldwin, M. M., Daynes, E., Hong, A., Mills, G., Goddard, A. C. N., Chaplin, E., Gardiner, N., Singh, S. J., & Your COVID Recovery® Development Group (2022). Early experiences of the Your COVID Recovery® digital programme for individuals with long COVID. BMJ open respiratory research, 9(1), e001237. https://doi.org/10.1136/bmjresp-2022-001237en_US
dc.identifier.other10.1136/bmjresp-2022-001237
dc.identifier.urihttp://hdl.handle.net/20.500.12904/16802
dc.description.abstractObjectives: To describe the early data from the Your COVID Recovery® digital programme and to explore the data collected from two embedded outcome measures. Design: Observational. Setting: Primary and secondary care (England-Online). Participants: 110 individuals completed the programme (68.1% female, 88.1% White British, age: 46.3 (10.8) years, weight: 86.5 (21.1) kg, height: 169.3 (10.0) cm). 47.2% of patients reported comorbidities. Intervention: Following an assessment by a healthcare professional, individuals with long COVID were offered access to the Your COVID Recovery® digital programme. The programme comprises of four stages for the participants to progress through. Participants are encouraged to record severity of their symptoms and amount of activity they are doing on a symptom and an activity tracker. Resources and interactive material on managing symptoms of long COVID are available throughout each stage. Primary outcome measures: Questionnaire (EuroQ0l 5-Dimension 5-Level (EQ-5D-5L) and the chronic obstructive pulmonary disease assessment test (CAT)) data were extracted from the site from 11 March 2021 until 9 November 2021. Results: Participants were on the programme for 8.6 (4.3) weeks. There was a statistically significant increase in EQ-5D-5L visual analogue scale (VAS) score (pre=48.8 (19.5); post=59.9 (22.1); p<0.01). The EQ-5D-5L Index Value preintervention to postintervention did improve but not significantly (pre=0.5 (0.3); post=0.6 (0.3); p=0.09). CAT total score improved significantly preintervention to postintervention (pre=19.8 (7.2); post=15.6 (7.6); p<0.01). All CAT item scores significantly improved preintervention to postintervention (p<0.005), except the phlegm item score (p=0.168). Discussion: This early data describes the impact of the Your COVID Recovery® digital programme on the first cohort of patients to complete the digital recovery programme. The outcome data are promising and should encourage uptake.
dc.description.urihttps://bmjopenrespres.bmj.com/content/9/1/e001237en_US
dc.language.isoenen_US
dc.subjectCOVID-19en_US
dc.titleEarly experiences of the Your COVID Recovery® digital programme for individuals with long COVIDen_US
dc.typeArticleen_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
rioxxterms.versionNAen_US
rioxxterms.versionofrecordhttp://dx.doi.org/10.1136/bmjresp-2022-001237en_US
rioxxterms.typeJournal Article/Reviewen_US
refterms.panelUnspecifieden_US
html.description.abstractObjectives: To describe the early data from the Your COVID Recovery® digital programme and to explore the data collected from two embedded outcome measures. Design: Observational. Setting: Primary and secondary care (England-Online). Participants: 110 individuals completed the programme (68.1% female, 88.1% White British, age: 46.3 (10.8) years, weight: 86.5 (21.1) kg, height: 169.3 (10.0) cm). 47.2% of patients reported comorbidities. Intervention: Following an assessment by a healthcare professional, individuals with long COVID were offered access to the Your COVID Recovery® digital programme. The programme comprises of four stages for the participants to progress through. Participants are encouraged to record severity of their symptoms and amount of activity they are doing on a symptom and an activity tracker. Resources and interactive material on managing symptoms of long COVID are available throughout each stage. Primary outcome measures: Questionnaire (EuroQ0l 5-Dimension 5-Level (EQ-5D-5L) and the chronic obstructive pulmonary disease assessment test (CAT)) data were extracted from the site from 11 March 2021 until 9 November 2021. Results: Participants were on the programme for 8.6 (4.3) weeks. There was a statistically significant increase in EQ-5D-5L visual analogue scale (VAS) score (pre=48.8 (19.5); post=59.9 (22.1); p<0.01). The EQ-5D-5L Index Value preintervention to postintervention did improve but not significantly (pre=0.5 (0.3); post=0.6 (0.3); p=0.09). CAT total score improved significantly preintervention to postintervention (pre=19.8 (7.2); post=15.6 (7.6); p<0.01). All CAT item scores significantly improved preintervention to postintervention (p<0.005), except the phlegm item score (p=0.168). Discussion: This early data describes the impact of the Your COVID Recovery® digital programme on the first cohort of patients to complete the digital recovery programme. The outcome data are promising and should encourage uptake.en_US
rioxxterms.funder.project94a427429a5bcfef7dd04c33360d80cden_US


This item appears in the following Collection(s)

Show simple item record